Search research articles
Contact Us
Filters
Showing results (1-10 of 20) with videos related to
Page
of 2
Sort By:
Bioanalysis
|
June 21, 2018
The FDA/critical path initiative/Duke-Margolis center for health policy public workshop on analytical validation of assays for biomarker qualification: an update on the White Paper
Steven P Piccoli
Bioanalysis
|
June 26, 2018
Biomarker assay validation
Steven P Piccoli, Fabio Garofolo
Bioanalysis
|
May 9, 2014
Conjugated critical reagent characterization for ligand-binding assays: using MALDI-TOF-MS as an orthogonal tool to assess assay performance
Jonathan Haulenbeek, Steven P Piccoli
Bioanalysis
|
June 9, 2023
Considerations for drug development biomarker assays in the clinical laboratory
Mark E Arnold, John L Allinson, Steven P Piccoli
Bioanalysis
|
May 17, 2014
Measuring biotherapeutics with endogenous counterparts and pre-existing antibodies: an interferon case study
Heather Myler, Tonya Felix, Jie Zhu, et al.
Clinical Chemistry
|
May 25, 2002
Clinical evaluation of the Elecsys total prostate-specific antigen assay on the Elecsys 1010 and 2010 systems
Alexander Haese, Robert T Dworschack, Steven P Piccoli, et al.
The AAPS Journal
|
April 27, 2016
Development and Validation of Electrochemiluminescence Assays to Measure Free and Total sSLAMF7 in Human Serum in the Absence and Presence of Elotuzumab
Jennifer Postelnek, Robert J Neely, Michael D Robbins, et al.
Bioanalysis
|
December 16, 2014
Targeting an acid labile aspartyl-prolyl amide bond as a viable alternative to trypsin digestion to generate a surrogate peptide for LC-MS/MS analysis
Eliza N Fung, Frank Zambito, Jonathan Haulenbeek, et al.
Journal of Biomedicine & Biotechnology
|
December 23, 2003
Optimization of Rolling-Circle Amplified Protein Microarrays for Multiplexed Protein Profiling
Weiping Shao, Zhimin Zhou, Isabelle Laroche, et al.
Parkinsonism & Related Disorders
|
January 30, 2023
Plasma and cerebrospinal fluid pharmacokinetics of vodobatinib, a neuroprotective c-Abl tyrosine kinase inhibitor for the treatment of Parkinson's disease
Ryan R Walsh, Nitin K Damle, Sanjay Mandhane, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 20) with videos related to
Sort By:
Page
of 2
Bioanalysis
|
June 21, 2018
The FDA/critical path initiative/Duke-Margolis center for health policy public workshop on analytical validation of assays for biomarker qualification: an update on the White Paper
Steven P Piccoli
Bioanalysis
|
June 26, 2018
Biomarker assay validation
Steven P Piccoli, Fabio Garofolo
Bioanalysis
|
May 9, 2014
Conjugated critical reagent characterization for ligand-binding assays: using MALDI-TOF-MS as an orthogonal tool to assess assay performance
Jonathan Haulenbeek, Steven P Piccoli
Bioanalysis
|
June 9, 2023
Considerations for drug development biomarker assays in the clinical laboratory
Mark E Arnold, John L Allinson, Steven P Piccoli
Bioanalysis
|
May 17, 2014
Measuring biotherapeutics with endogenous counterparts and pre-existing antibodies: an interferon case study
Heather Myler, Tonya Felix, Jie Zhu, et al.
Clinical Chemistry
|
May 25, 2002
Clinical evaluation of the Elecsys total prostate-specific antigen assay on the Elecsys 1010 and 2010 systems
Alexander Haese, Robert T Dworschack, Steven P Piccoli, et al.
The AAPS Journal
|
April 27, 2016
Development and Validation of Electrochemiluminescence Assays to Measure Free and Total sSLAMF7 in Human Serum in the Absence and Presence of Elotuzumab
Jennifer Postelnek, Robert J Neely, Michael D Robbins, et al.
Bioanalysis
|
December 16, 2014
Targeting an acid labile aspartyl-prolyl amide bond as a viable alternative to trypsin digestion to generate a surrogate peptide for LC-MS/MS analysis
Eliza N Fung, Frank Zambito, Jonathan Haulenbeek, et al.
Journal of Biomedicine & Biotechnology
|
December 23, 2003
Optimization of Rolling-Circle Amplified Protein Microarrays for Multiplexed Protein Profiling
Weiping Shao, Zhimin Zhou, Isabelle Laroche, et al.
Parkinsonism & Related Disorders
|
January 30, 2023
Plasma and cerebrospinal fluid pharmacokinetics of vodobatinib, a neuroprotective c-Abl tyrosine kinase inhibitor for the treatment of Parkinson's disease
Ryan R Walsh, Nitin K Damle, Sanjay Mandhane, et al.
Page
of 2